Open Call SC1-HCC-04-2018: Digital Health and Care Services - Support for Strategy and (Early) Adoption
Health and care service providers and users are increasingly facing complex decisions when exploring and investing in new health and care solutions. There is a need to support cross-border cooperation in preparation of procurement of research and innovative digital solutions, including on how to balance innovation risks with improved outcomes.
Read more ...
ProEmpower Releases Call for Tenders to Develop Innovative ICT for Diabetes Mellitus Self-Management
The ProEmpower procurers are looking for a diabetes management solution that will tackle the unmet needs in the current treatment of diabetes such as the fragmentation in today’s healthcare systems, the overreliance on and the ineffectiveness of pharmacotherapy, the late detection of the disease and the frequency of severe complications. This will be achieved by providing personalised and multi-disciplinary care to diabetes patients and empowering them to become responsible actors in the care process.
Read more ...
Open Call SC1-DTH-08-2018: Prototyping a European Interoperable Electronic Health Record (EHR) Exchange
Large amounts of valuable health data are generated and collected during and between citizens' medical examinations across Europe. However, opportunities to reuse these data for research and better healthcare are often missed because health data continue to be confined in data silos, often not matching semantic standards, quality needs and safe data exchange techniques.
Read more ...
Open Call SC1-DTH-07-2018: Exploiting the Full Potential of in-Silico Medicine Research for Personalised Diagnostics and Therapies in Cloud-Based Environments
The progress in computer modelling and simulation applied in disease management is a European strength and various Decision Support Systems have been developed for different medical disciplines. While the market is developing today, addressing the need of more precise and personalised diagnostics and treatments, the proposed software tools and platforms often need to further conquer visibility and trust from users and investors to get implemented in the routine clinical practice.
Read more ...
Cancer, Neurodegenerative Disease and Medicines Safety Feature in New IMI Call for Proposals
The Innovative Medicines Initiative (IMI) is launching a new Call for proposals covering diabetes, antimicrobial resistance, neurodegenerative diseases, cancer, and medicines safety during pregnancy and breastfeeding, to name just a few. The total budget of the Call is EUR 223 million, around half of which comes from the EU's Horizon 2020 programme, and half of which comes from EFPIA companies and IMI Associated Partners.
Read more ...
Health and care service providers and users are increasingly facing complex decisions when exploring and investing in new health and care solutions. There is a need to support cross-border cooperation in preparation of procurement of research and innovative digital solutions, including on how to balance innovation risks with improved outcomes. 
The Innovative Medicines Initiative (IMI) is launching a new Call for proposals covering diabetes, antimicrobial resistance, neurodegenerative diseases, cancer, and medicines safety during pregnancy and breastfeeding, to name just a few. The total budget of the Call is EUR 223 million, around half of which comes from the EU's Horizon 2020 programme, and half of which comes from EFPIA companies and IMI Associated Partners.